MedTrace Logo

Method Optimization for the Quantification of the NAD

NCT05561712 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-09-30

No results posted yet for this study

Summary

Method optimization for the quantification of the NAD metabolome in human whole blood, and evaluation of baseline inter and intra-subject variability.

Conditions

  • NAD

Interventions

OTHER

Laboratory method validation

Test several sampling conditions

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Cuenoud Bernard · Nestle Health Science

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-25
Primary Completion
2022-03-15
Completion
2022-03-15

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05561712 on ClinicalTrials.gov